Received Sep 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Had a high fever from the second shot; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: Had a high fever from the second shot). The outcome of the fever was resolved (duration 1 day). It was unknown if the reporter considered the fever to be related to Shingles vaccine. It was unknown if the company considered the fever to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 05-SEP-2025 This case was reported by a patient via interactive digital media. The high fever was gone in a day.